Modulation of conductivity of alginate hydrogels containing reduced graphene oxide through the addition of proteinsShow others and affiliations
2021 (English)In: Pharmaceutics, E-ISSN 1999-4923, Vol. 13, no 9, p. 1473-, article id 1473
Article in journal (Refereed) Published
Abstract [en]
Modifying hydrogels in order to enhance their conductivity is an exciting field with applications in cardio and neuro-regenerative medicine. Therefore, we have designed hybrid alginate hydrogels containing uncoated and protein-coated reduced graphene oxide (rGO). We specifically studied the adsorption of three different proteins, BSA, elastin, and collagen, and the outcomes when these protein-coated rGO nanocomposites are embedded within the hydrogels. Our results demon-strate that BSA, elastin, and collagen are adsorbed onto the rGO surface, through a non-spontaneous phenomenon that fits Langmuir and pseudo-second-order adsorption models. Protein-coated rGOs are able to preclude further adsorption of erythropoietin, but not insulin. Collagen showed better adsorption capacity than BSA and elastin due to its hydrophobic nature, although requiring more energy. Moreover, collagen-coated rGO hybrid alginate hydrogels showed an enhancement in conductivity, showing that it could be a promising conductive scaffold for regenerative medicine.
Place, publisher, year, edition, pages
MDPI AG , 2021. Vol. 13, no 9, p. 1473-, article id 1473
Keywords [en]
Alginate, Collagen, Conductivity, Hydrogel, Reduced graphene oxide, alginic acid, bovine serum albumin, collagen type 1, elastin, erythropoietin, graphene oxide, nanocomposite, adsorption, Article, chemical composition, coating (procedure), cyclic voltammetry, electric conductance, electrochemical analysis, enthalpy, entropy, Fourier transform infrared spectroscopy, frequency modulation, hydrophobicity, impedance spectroscopy, process design, Raman spectrometry, regenerative medicine, surface area, thermodynamics
National Category
Materials Chemistry
Identifiers
URN: urn:nbn:se:kth:diva-311758DOI: 10.3390/pharmaceutics13091473ISI: 000701446100001PubMedID: 34575549Scopus ID: 2-s2.0-85115153598OAI: oai:DiVA.org:kth-311758DiVA, id: diva2:1655962
Note
QC 20220504
2022-05-042022-05-042024-07-04Bibliographically approved